BCDA: BioCardia, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 10.64
Enterprise Value ($M) 5.71
Book Value ($M) 2.75
Book Value / Share 0.60
Price / Book 3.86
NCAV ($M) 1.54
NCAV / Share 0.34
Price / NCAV 6.90

Profitability (mra)
Return on Invested Capital (ROIC) -2.03
Return on Assets (ROA) -2.59
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 1.78
Current Ratio 1.78

Balance Sheet (mrq) ($M)
Current Assets 5.06
Assets 6.27
Liabilities 3.51
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
09-06 13G Intracoastal Capital, Llc 4.99
04-05 13D/A Frost Gamma Investments Trust 4.80 -18.12
02-14 13G/A Satterfield Thomas A Jr 7.87 49.26
2024-02-02 13G/A Francis Capital Management, LLC 0.00 -100.00

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-31 26,545 87,507 30.33
2025-01-30 3,713 15,303 24.26
2025-01-29 13,842 33,452 41.38
2025-01-28 14,013 78,283 17.90

(click for more detail)

Similar Companies
AVTX – Avalo Therapeutics, Inc. AWH – Aspira Women's Health Inc.
AYTU – Aytu BioPharma, Inc. BCLI – Brainstorm Cell Therapeutics Inc.
BCTX – BriaCell Therapeutics Corp.


Financial data and stock pages provided by
Fintel.io